UTHR SCHEDULE 13G/A: SEC filing
United Therapeutics Corporation
Filed with the SEC on · accession 0001104659-26-122747
UTHR filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 4, 2026. United Therapeutics Corporation filed a Schedule 13G/A, an amendment to a previously filed passive ownership statement. The stock moved +1.2% by the first close after the filing.
Summary of the filing
United Therapeutics Corporation filed a Schedule 13G/A, an amendment to a previously filed passive ownership statement. The filing indicates a change in a holder's passive stake in the company.
Key details
How UTHR stock reacted
Close before
$601.32
Nov 3, 2026
First close after
+1.19%
$608.49
5 trading days
—
Since filing
-5.92%
$565.72
✦ Ask GOAX AI about this filing — what it means for UTHR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for UTHR?
Click hereFrequently asked questions
What did UTHR file with the SEC on Nov 4, 2026?
UTHR filed a SCHEDULE 13G/A (SEC filing). United Therapeutics Corporation filed a Schedule 13G/A, an amendment to a previously filed passive ownership statement. The filing indicates a change in a holder's passive stake in the company.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did UTHR stock react to this filing?
UTHR closed at $601.32 before the filing and $608.49 on Nov 4, 2026 (+1.19%).
Other UTHR SEC filings
Get alerts when UTHR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days